{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:15:51Z","timestamp":1794348951306,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["2410026"],"award-info":[{"award-number":["2410026"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["3133200"],"award-info":[{"award-number":["3133200"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["6905134"],"award-info":[{"award-number":["6905134"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.xkme.2022.100569","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:36:43Z","timestamp":1668393403000},"page":"100569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Lingfeng","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston Wing-Shing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Chun-Kau","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xkme.2022.100569_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2022.100569_bib2","first-page":"43","article-title":"Epidemiology and pathogenesis of diabetic nephropathy","volume":"59","author":"Shimizu","year":"2017","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"suppl 4","key":"10.1016\/j.xkme.2022.100569_bib3","doi-asserted-by":"crossref","first-page":"iv96","DOI":"10.1093\/ndt\/gfv119","article-title":"Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression","volume":"30","author":"Schutte","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2022.100569_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ekir.2018.12.001","article-title":"Multimarker panels in diabetic kidney disease: the way to improved clinical trial design and clinical practice?","volume":"4","author":"Perco","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2022.100569_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fgene.2020.00993","article-title":"MicroRNAs in podocyte injury in diabetic nephropathy","volume":"11","author":"Ishii","year":"2020","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.semnephrol.2012.06.010","article-title":"VEGF and podocytes in diabetic nephropathy","volume":"32","author":"Tufro","year":"2012","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1523-1755.2003.00339.x","article-title":"Urinary podocytes: lost and found alive","volume":"64","author":"Mundel","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2022.100569_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/0886022X.2011.649627","article-title":"Relationship between urinary podocytes and kidney diseases","volume":"34","author":"Sun","year":"2012","journal-title":"Ren Fail"},{"key":"10.1016\/j.xkme.2022.100569_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cca.2021.10.017","article-title":"Urinary podocyte markers in kidney diseases","volume":"523","author":"Zeng","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.xkme.2022.100569_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00125-020-05297-z","article-title":"Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes","volume":"64","author":"Sullivan","year":"2021","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.xkme.2022.100569_bib11","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1152\/ajprenal.00399.2018","article-title":"Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria","volume":"317","author":"Zhang","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.xkme.2022.100569_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036041","article-title":"Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study","volume":"7","author":"Jim","year":"2012","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.xkme.2022.100569_bib13","first-page":"83","article-title":"Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria","volume":"39","author":"Kostovska","year":"2020","journal-title":"J\u00a0Med Biochem"},{"key":"10.1016\/j.xkme.2022.100569_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13098-017-0228-y","article-title":"Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus","volume":"9","author":"Petrica","year":"2017","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.xkme.2022.100569_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75320-1","article-title":"Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy","volume":"10","author":"Fukuda","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.xkme.2022.100569_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-07-0708","article-title":"Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker","volume":"158","author":"Wang","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.xkme.2022.100569_bib17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1681\/ASN.2008070782","article-title":"The role of podocalyxin in health and disease","volume":"20","author":"Nielsen","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"15","key":"10.1016\/j.xkme.2022.100569_bib18","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1242\/jcs.01163","article-title":"Enhanced podocalyxin expression alters the structure of podocyte basal surface","volume":"117","author":"Economou","year":"2004","journal-title":"J\u00a0Cell Sci"},{"issue":"11","key":"10.1016\/j.xkme.2022.100569_bib19","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","article-title":"Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin","volume":"55","author":"Hara","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.xkme.2022.100569_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/1354750X.2015.1118551","article-title":"Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes","volume":"21","author":"Shoji","year":"2016","journal-title":"Biomarkers"},{"issue":"9","key":"10.1016\/j.xkme.2022.100569_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xkme.2022.100569_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-62703-453-1_17","article-title":"Methods of microRNA quantification in urinary sediment","volume":"1024","author":"Wang","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.xkme.2022.100569_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/dmrr.2654","article-title":"Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy","volume":"31","author":"Wang","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.xkme.2022.100569_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2018.05.036","article-title":"Urinary mitochondrial DNA level in non-diabetic chronic kidney diseases","volume":"484","author":"Wei","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib25","doi-asserted-by":"crossref","first-page":"c169","DOI":"10.1159\/000104428","article-title":"Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy","volume":"106","author":"Wang","year":"2007","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib26","first-page":"233","article-title":"Role of urinary podocalyxin in early diagnosis of diabetic nephropathy","volume":"58","author":"Kostovska","year":"2020","journal-title":"Rom J Intern Med"},{"issue":"8","key":"10.1016\/j.xkme.2022.100569_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2217\/bmm-2018-0152","article-title":"Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases","volume":"12","author":"Akankwasa","year":"2018","journal-title":"Biomark Med"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","article-title":"Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome","volume":"1","author":"Kestil\u00e4","year":"1998","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.xkme.2022.100569_bib29","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.kint.2016.10.046","article-title":"Fast renal\u00a0decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes","volume":"91","author":"Krolewski","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2022.100569_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","article-title":"Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat","volume":"60","author":"Kim","year":"2001","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2022.100569_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xkme.2022.100569_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000188509","article-title":"Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis","volume":"69","author":"Hara","year":"1995","journal-title":"Nephron"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059522002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:24:38Z","timestamp":1762910678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059522002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2590059522002023"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100569","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100569"}}